Plus Therapeutics (PSTV) Misses Q4 EPS by 424c

Plus Therapeutics (NASDAQ: PSTV) reported Q4 EPS of ($4.24). Revenue for the quarter came in at $4.91 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
• Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions